Список литературы

1. Ахмедова Ш.А. Состояние молочных желез у женщин после 40 лет с нарушениями функции щитовидной железы. Дисс. ... канд. мед. наук / ГОУ ВПО "Ростовский государственный медицинский университет".

2. Байлюк Е.Н. Клинико-морфологические особенности пролиферативных процессов в молочной железе у больных миомой матки. // Журнал акушерства и женских болезней. 2010. Т. 59. Вып. 1. С. 98-105.

3. Белилова Н.С., Белилов Ф.И. Факторы риска и профилактика рака. Часть II. // Клиническая медицина. 2005. №12. С. 20-24.

4. Бурдина Л.М. Дисгормональные гиперплазии молочных желез - особенности развития, дифференциальная диагностика. // Радиология - Практика. 2007. №3. С. 44-61.

5. Бусько Е.А., Семенов Е.А., Семиглазов В.В. Возможности соноэластографии в диагностике опухолей молочных желез размерами до 2 см. // Вопросы онкологии. 2012. Т. 58. №3. С. 359-362

6. Веснин С.Г., Каплан М.А., Авакян Р.С. Современная микроволновая радиотермометрия молочных желез. // Опухоли женской репродуктивной системы. Маммология / Онкогинекология. 2008. №3. С. 28-33.

7. Высоцкая И.В. Современные возможности терапии фибрознокистозной болезни. // Опухоли женской репродуктивной системы. Маммология / Онкогинекология. 2009. №1-2. С. 44-52.

8. Герасимов А.Н. Медицинская статистика: учебное пособие. М.: ООО «Медицинское информационное агентство», 2007. 480 с.

9. Гилязутдинов И.А., Хасанов Р.Ш. Доброкачественные опухоли молочных желез: Руководство для врачей. Казань: Медлитература, 2007. 216 с.

10. Добренький М.Н, Добренькая Е.М. Влияние функционального состояния щитовидной железы на прогноз у больных гормональными гиперплазиями и раком молочной железы. // Фундаментальные исследования. 2008. №8. С. 48-49.

11. Доброкачественные заболевания молочных желез: рук-во по диагностике и лечению / под ред. О.С. Филиппова. М.: МЕДпресс- информ, 2008.

12. Жариков А.А., Паршин В.С. Роль инструментального скрининга и его эффективность в ранней диагностике доброкачественных и злокачественных заболеваний молочной железы. // Опухоли женской репродуктивной системы. Маммология / Онкогинекология. 2007. №4. С. 17-22.

13. Жариков А.А., Паршин В.С, Нархова Н.П. Ранняя инструментальная диагностика доброкачественных и злокачественных заболеваний молочных и щитовидной железы. // Ультразвуковая и функциональная диагностика. 2009. №1. С. 100-106.

14. Заболевания щитовидной железы. / Г.М. Кроненберг, Ш. Мелмед, К.С. Полонски, П.Р. Ларсен; пер. с англ. под ред. И.И. Дедова, Г.А. Мельниченко. М.: ООО «Рид Элсивер», 2010. С. 215-296.

15. Заболотская Н.В., Заболотский В.С. Новые технологии в ультразвуковой маммографии. М.: ООО «Фирма СТРОМ». 2010. 256 с.

16. Запирова С.Б., Берщанская А.М., Чазова Н.Л., Рожкова Н.И. Современная классификация и особенности клиникорентгеносонопатоморфологических проявлений различных форм мастопатии. // Опухоли женской репродуктивной системы. Маммология / Онкогинекология. 2009. №1-2. С. 10-15.

17. Захарова Н.А., Семиглазов В.Ф., Duffy S.W. Скрининг рака молочной железы: проблемы и решения. М.: ГЭОТАР-Медиа, 2011. 175 с.

18. Зернов Д.И., Лукьянченко А.Б. Динамическая магнитно-резонансная маммография в дифференциальной диагностике неопределенных

узловых или очаговых изменений (при подозрении на рак). // Медицинская визуализация. 2006. №6. С. 99-106.

19. Зикиряходжаев А.Д., Летягин В.П., Корженкова Г.П., Волченко А.А. Диагностическая ценность ультразвукового исследования при раке молочной железы у женщин молодого возраста. // Российский онкологический журнал. 2008. №2. С. 29-30.

20. Злокачественные заболевания в России в 2012 году (заболеваемость и смертность). Под. ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: ФГБУ «МНИОИ им. П.А. Герцена Минздравсоцразвития России», 2014. 250 с.

21. Клиническая маммология (практическое руководство). Под ред. М.И. Давыдова, В.П.

22. Клюшкин И.В., Пасынков Д.В., Насруллаев М.Н., Пасынкова О.В. Эффективность ультразвукового скрининга рака молочной железы у больных фиброзно-кистозной болезнью. // Казанский медицинский журнал. 2009. Т. 90. №2. С. 220-222.

23. Коган И.Ю., Полянин А.А., Тарасова М.А. и др. Исследование молочных желез в практике акушера-гинеколога. СПб.: Издательство Н-Л, 2004. 24 с.

24. Коган И.Ю., Тарасова М.А., Мясникова М.О. Мастопатия: фибрознокистозная болезнь молочных желез (патогенез, диагностика, лечение): учебно-методическое пособие. Под ред. Э.К. Айламазяна. СПб.: ООО «Изд-во Н-Л». 2008. 52 с.

25. Корженкова Г.П., Курдюкова Л.Н., Иванкина О.В. Скрининг рака молочной железы. // Вестник Российского онкологического научного центра имени Н. Н. Блохина РАМН. 2004. №1-2. С. 53-56.

26. Кулагина Н.В. Доброкачественные заболевания молочных желез: учебное пособие. 2-е изд. М.: ООО «Типография «Печатных дел мастер», 2012. 64 с.

27. Летягин В.П., Высоцкая И.В., Ким Е.А. Факторы риска развития рака молочной железы. // Маммология. 2006. №4. С. 10-12.

28. Лифшиц В.М., Сидельникова В.И. Медицинские лабораторные анализы. Справочник. Издание третье, исправленное и дополненное. М.: «Триада-Х», 2007. С. 122-126.

29. Матхев С. Маммографический скрининг рака молочной железы у женщин Индии. Дисс. ... канд. мед. наук / ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М. Сеченова. Москва, 2012. 171 с.

30. Мурадова Д.Б. Особенности дисгормональных заболеваний молочных желез у девочек и девушек с гинекологической патологией. Дисс. ... канд. мед. наук / Таджикский НИИ Акушерства, гинекологии и перинатологии. Душанбе, 2012. 102 с.

31. Мустафин Ч.К. Комплексная диагностика и лечение диффузной мастопатии. // Лечащий врач. 2011. №11. URL: http://www.lvrach.ru/ 2011/11/15435297/. (Дата обращения 17.03.2014 г.).

32. Мустафин Ч.К., Кузнецова С.В. Дисгормональные болезни молочной железы. Под ред. Е.Г. Пинхосевича.

33. Перминова С.Г. Гипотиреоз и нарушения репродуктивной функции женщины. // Гинекология. М. 2006. 8. №1. С.21-26.

34. Петунина Н.А. Субклинический гипотиреоз: подходы к диагностике и лечению. // Трудный пациент. 2006. №2. С. 30-35.

35. Позитронная эмиссионная томография. Руководство для врачей. [Под ред. Гранова А.М., Тютина Л.А.]. СПб.: 2008. С. 66-78.

36. Прилепская В.Н., Волобуев А.И., Швецова О.Б. Масталгия у женщин репродуктивного возраста: клиника, диагностика, лечение. // Гинекология. 2003. Т. 5. №4. С. 20-24.

37. Радзинский В.Е., Ордиянц И.И. Комплексный подход к диагностике и лечению гинекологических и маммологических заболеваний // Маммолог. 2005. №1. С. 12-17.

38. Рожкова Н.И., Бурдина И.И., Меских Е.В., Мазо М.Л. Диффузные доброкачественные заболевания молочной железы. Диагностика и лечение: руководство для врачей. [Под. ред. В.А, Солодкого, Н.И. Рожковой]. М.: Спец. изд-во. мед. кн., 2012. 124 с.

39. Рожкова Н.И., Смирнова Н.А., Назаров А.А. Факторы, влияющие на эффективность радиотермометрических измерений молочной железы с помощью диагностического комплекса РТМ-01-РЭС. // Опухоли женской репродуктивной системы. Маммология / Онкогинекология. 2007. №3. С. 21-25.

40. Семиглазов В.Ф., Семиглазов В.В., Клецель А.Е. Неинвазивные и инвазивные опухоли молочной железы. СПб.: Боргес, 2005. 350 с.

41. Сергиенко М.Ю. Эпидемиология и факторы риска развития подростковой мастопатии. // Медико-сощальни проблемы гімї. 2011. Т.

4. №16. С. 48-51.

42. Серебрякова С.В., Труфанов Г.Е., Юхно Е.А. Магнитно-резонансная семиотика рака молочной железы. // Опухоли женской репродуктивной системы. Маммология / Онкогинекология. 2009. №3-4. С. 20-25.

43. Синюкова Г.Т., Шолохов В.Н., Данзанова Т.Ю. Ультразвуковая томография и допплерография в оценке эффективности лекарственного лечения рака молочной железы. // Sonoace international (Русская версия). 2003. №11. С. 25-28.

44. Сухарева Е.А., Пономарева Л.А. Характеристика заболеваний молочных желез у девушек-подростков, обратившихся в маммологический кабинет поликлиники.

45. Тагиева Т.Т. Доброкачественные заболевания молочных желез у женщин позднего репродуктивного возраста. Гинекология. 2001. Т. 3. №3. С. 107-110.

46. Тагиева Т.Т. Доброкачественные узловые образования молочных желез у женщин репродуктивного возраста. // Вестник РОНЦ им. Н. Н. Блохина РАМН. 2007. Т. 18. №4. с. 54-58.

47. Тагиева Т.Т. Фиброзно-кистозная мастопатия. // Гинекология. 2005. Т. 7. №3. С. 141-144.

48. Терновой С.К., Абдураимов А.Б. Лучевая маммология. М.: ГЭОТАР- Медиа. 2007, 128 с.

49. Тицкая А.А., Чернов В.И., Слонимская Е.М., Синилкин И.Г. Маммосцинтиграфия с 199T1 в диагностике рака молочной железы. // Сибирский онкологический журнал. 2008. Т. 30. №6. С. 5-10.

50. Трошина Е.А., Юкина М.Ю. Синдром гипотиреоза. // Клиницист. 2008. №1. С. 45-50.

51. Труфанов Г.Е.. Рязанов В.В., Иванова Л.И. УЗИ с эластографией в маммологии. СПб.: ЭЛБИ-СПб, 2013. 256 с.

52. Трынченкова Н.Н., Слонимская Е.М., Кравец Е.Б. Влияние тиреоидного статуса на формирование дисгормональных заболеваний молочной железы. // Сибирский онкологический журнал. 2005. №4. С. 21-26.

53. Фадеев В.В. Современные принципы диагностики и лечения гипотиреоза. // Земский врач. 2010. №2. С. 13-16.

54. Федосова Л.Н., Сотникова Л.С., ЭльАкад Е.В. Сочетание диффузной доброкачественной дисплазии молочных желез с вегетативной дисфункцией. // Сибирский медицинский журнал. 2010. Т. 25. №4. Вып. 2. С. 94-96.

55. Фишер У., Баум Ф., Люфтнер-Нагель С. Заболевания молочных желез [пер. с англ. под общей редакцией чл.- кор. РАМН, проф. Б.И. Долгушина. М. МЕДпресс-информ. 2009. С. 12-13. 255 с.

56. Хохлова Е.А., Зубарев А.В., Рожкова Н.И. Возможности соноэластографии в уточняющей диагностике заболеваний молочных

желез. // Вестник Российского научного центра рентгенорадиологии. 2011. №11. С. 41-48.

57. Юренева С.В., Коновалова В.Н., Сметник В.П. Заместительная гормонотерапия: дискредитация и реабилитация (обзор литературы).

58. Alowami S., Troup S., Al-Haddad S. et al. Mammographic density is related to stroma and stromal proteoglycan expression. // Breast Cancer Res. 2003. №5. P. R129-R135.

59. Altieri A., Tavani A., Gallus S., et al. Correspondence re: Simon et al., Do thyroid disorders increase the risk of breast cancer? // Cancer Epidemiol. Biomarkers Prev. 2003. №12. P. 684.

60. Amalu W.C., Hobbins W.B., Head J.F., Elliott R.L. Infrared imaging of the breast - an overview. // In: Biomedical Engineering Handbook. CRC Press. 2006. Chpt. 25. P. 1-36.

61. American College of Radiology. BI-RADS Breast imaging reporting abd data system. Breast imaging atlas: mammography, breast ultrasound, breast MR-imaging. Virginia. Reston. 2003. 268 p.

62. Amin A.L., Purdy A.C., Mattingly J.D. et al. Benign breast disease. // Surg. Clin. North. Am. 2013. Vol. 93. №2. Р. 299-308.

63. Anderson W.F., Katki H.A., Rosenberg P.S. Incidence of breast cancer in the United States: current and future trends. // J. Natl. Cancer Inst. 2011. Vol. 103. №18. P. 1397-1402.

64. Angelousi A.G., Anagnostou V.K., Stamatakos M.K. et al. Primary hypothyroidism and risk for breast cancer: a systematic review and metaanalysis. // Eur. J. Endocrinol. 2012. Vol. 166. №3. Р. 373-381.

65. Assi V., Warwick J., Cuzick J., Duffy S.W. Clinical and epidemiological issues in mammographic density. // Nat. Rev. Clin. Oncol. 2011. Vol. 9. №1. P. 33-40.

66. Assi H.A., Khoury K.E., Dbouk H. et al. Epidemiology and prognosis of breast cancer in young women. // J. Thorac. Dis. 2013. Vol. 5. Suppl. 1. P. S2-S8.

67. Athanasiou A, Tardivon A, Ollivier L. et al. How to optimize breast ultrasound. // Eur. J. Radiol. 2009. Vol. 69. №1. P. 6-13.

68. Athanasiou A., Tardivon A., Tanter M. et al. Breast lesions: quantitative elastography with supersonic shear imaging - preliminary results. // Radiology. 2010. Vol. 256. №1. P. 297-303.

69. Aytac B., Sahsine T., Erturk F.Y. et al. Evaluation of incidence and histolopathological findings of breast lesions in reduction mammoplasty specimens: Uludag University experience. // J. Pak. Med. Assoc. 2013. Vol. 63. №7. Р. 878-881.

70. Baer H.J., Schnitt S.J., Connolly J.L. et al. Early life factors and incidence of proliferative benign breast disease. // Cancer Epidemiol. Biomarkers Prev. 2005. Vol. 14. №12. P. 2889-2897.

71. Baker J.A., Lo J.Y. Breast tomosynthesis: state-of-the-art and review of the literature. // Acad. Radiol. 2011. Vol. 18. №10. Р. 1298-1310.

72. Barr R.G., Lackey A.E. The utility of the “bull’s-eye” artifact on breast elasticity imaging in reducing breast lesion biopsy rate. // Ultrasound Q.

2011. Vol. 27. №3. P. 151-155.

73. Benard F., Turcotte E. Imaging breast cancer with single photon computed tomography and positron emission tomography. // Breast Cancer Res. 2005. №7. Р. 153-162.

74. Berg W.A., Birdwell R.I., Gombos E.C. et al. Diagnostic imaging. Breast. Amirsys. Salt Lake City, 2006. 955 p.

75. Berg W.A., Campassi C.I., Ioffe O.B. Cystic lesions of the breast: sonographic-pathologic correlation. // Radiology. 2003. Vol. 227. №1. P. 183-191.

76. Berghammer P., Sinzinger H. The efficacy of 99mTc-MTBT scintimammography in the evaluation of breast lesions and axillary involvement. // Hell. J. Nucl. Med. 2011. Vol. 14. №1. P. 83.

77. Bernardi D., Ciatto S., Pellegrini M. Application of breast tomosynthesis in screening: incremental effect on mammography acquisition and reading time. // Br. J. Radiol. 2012. №85. P. 1174-1178.

78. Bernardi D., Ciatto S., Pellegrini M. et al. Prospective study of breast tomosynthesis as a triage to assessment in screening. // Breast Cancer Res. Treat. 2012. Vol. 133. №1. P. 267-271.

79. Bertelsen L., Mellemkjaer L., Balslev E., Olsen J.H. Benign breast disease among first-degree relatives of young breast cancer patients. // Am. J. Epidemiol. 2008. Vol. 168. №3. С. 261-267.

80. Bhargav P.R., Mishra A., Agarwal G. et al. Prevalence of hypothyroidism in benign breast disorders and effect of thyroxine replacement on the clinical outcome. // World J. Surg. 2009. Vol. 33. №10. P. 2087-2093.

81. Bick U., Engelken F., Diederichs G. et al. MRT of the Breast as Part of the Assessment in Population-Based Mammography Screening. // Rofo. 2013. Vol. 185. №9. P. 849-856.

82. Blohmer J.U., Reinhardt M., Schmalisch G. et al. Videodensitometry in the examination of focal breast lesions after injection of an ultrasound contrast agent. // Anticancer research. 2006. Vol. 26. №2. P. 1691-1698.

83. Bolan B.J., Nelson M.T., Yee D., Garwood M. Imaging in breast cancer: Magnetic resonance spectroscopy of the breast. // Breast Cancer Res. 2005. №7. Р. 149-152.

84. Boyd N.F. Mammographic density and risk of breast cancer. // Am. Soc. Clin. Oncol. Educ. Book. 2013. P. 57-62.

85. Boyd N.F., Martin L.J., Yaffe M.J., Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. // Breast Cancer Res. 2011. Vol. 13. №6. URL: http://breast-cancer-research.com/ content/13/6/223. (Дата последнего обращения 23.03.2014 г.).

86. Boyd N.F., Guo H., Martin L.J. et al. Mammographic density and the risk and detection of breast cancer. // NEJM. 2007. №356. P. 227-236

87. Boyle P. Breast cancer control: Signs of progress, but more work required. // The Breast. 2005. Vol. 17. P. 429-438.

88. Bray F., Ren J.S., Masuyer E., Ferlay J. Estimates of global cancer prevalence for 27 sites in the adult population in 2008. // Int. J. Cancer. 2013. Vol. 132. №5. P. 1133-1145.

89. Brem R.F., Rapelyea J.A., Zisman G. et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. // Radiology. 2005. №237. Р. 274-280.

90. Brind J. The abortion-breast cancer connection. // Issues Law Med. 2005. Vol. 21. №2. P. 109-135.

91. Brkljacic B, Miletic D, Sardanelli F. Thermography is not a feasible method for breast cancer screening. // Coll. Antropol. 2013. Vol. 37. №2. P. 589-593.

92. Brown A.P., Chen J., Hitchcock Y.J. et al. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. // J. Clin. Endocrinol. Metab. 2008. Vol. 93. №2. P. 504-515.

93. Burnside E.S., Hall T.J., Sommer A.M. et al. Differentiating benign from malignant solid breast masses with US strain imaging // Radiology. 2007. V. 245. №2. Р. 401-410.

94. Busilacchi P., Draghi F., Preda L., Ferranti C. Has color Doppler a role in the evaluation of mammary lesions? // J. Ultrasound. 2012. Vol. 15. №2. P. 93-98.

95. Byrne C., Schairer C., Brinton L.A. et al. Effects of mammographic density and benign breast disease on breast cancer risk. // Cancer Causes Control. 2001. Vol. 12. №2. P. 103-110.

96. Candelaria R.P., Hwang L., Bouchard R.R., Whitman G.J. Breast ultrasound: current concepts. // Semin. Ultrasound CT MR. 2013. Vol. 34. №3. P. 213-225.

97. Carney P.A., Bogart T.A., Geller B.M. et al. Association between time spent interpreting, level of confidence, and accuracy of screening mammography. // AJR Am. J. Roentgenol. 2012. Vol. 198. №4. P. 970-978.

98. Caumo F., Carbognin G., Casarin A. et al. Angiosonography in suspicious breast lesions with non-diagnostic FNAC: comparison with power Doppler US. // Radiol. Med. 2006. Vol. 111. №1. P. 61-72.

99. Celis J.E., Moreira J.M., Gromova I. et al. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia. // Mol. Oncol. 2007. Vol. 1. № 1. P. 97-119.

100. Cengiz O., Bozkurt B., Unal B. et al. The relationship between prognostic factors of breast cancer and thyroid disorders in Turkish women. // J. Surg. Oncol. 2004. Vol. 87. №1. P. 19-25.

101. Chao T.C., Luo Y.F., Chen S.C., Chen M.F. Color Doppler ultrasound in breast carcinomas: relationship with hormone receptors, DNA ploidy, S- phase fraction, and histopathology. // Ultrasound in medicine and biology. 2001. Vol. 27. №3. P. 351-355.

102. Chen S.T., Kuo S.J., Wu H.K. et al. Power Doppler breast ultrasound: association of vascularization and ER/c-erbB-2 co-expression in invasive breast carcinoma. // Breast Cancer. 2013. Vol. 20. №2. P. 152-158.

103. Chen X., Moore M.O., Lehman C.D. et al. Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy. // Acad. Radiol. 2004. №11. P. 1115-1124.

104. Chiorean A.R., Duma M.M., Dudea S.M. et al. Typical and unusual sonoelastographic patterns of breast cystic lesions: impact on BI-RADS classification. // Ultraschall Med. 2012. Vol. 33. №7. P. 138-144.

105. Chiu S.Y., Duffy S., Yen A.M. et al. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. // Cancer Epidemiol. Biomarkers Prev. 2010. №19. P. 1219-1228.

106. Cho N., Jang M., Lyou C.Y. Distinguishing benign from malignant masses at breast US: combined US elastography and color doppler US - influence on radiologist accuracy. // Radiology. 2012. Vol. 262. №1. P. 80-90.

107. Cho N., Moon W.K., Park J.S. et al. Nonpalpable breast masses: evaluation by US elastography. // Korean J. Radiol. 2008. Vol. 9. №2. P. 111-118.

108. Choi B.B., Kim S.H., Park C.S. et al. Radiologic findings of lobular carcinoma in situ: mammography and ultrasonography. // J. Clin. Ultrasound.

2011. Vol. 39. №2. P. 59-63.

109. Col N.F., Surks M.I., Daniels G.H. Subclinical thyroid disease: clinical applications. // JAMA. 2004. Vol. 291. №2. P. 239-243.

110. Colin C., Prince V., Valette P.J. Can mammographic assessments lead to consider density as a risk factor for breast cancer? // Eur. J. Radiol. 2013. Vol. 82. №3. P. 404-411.

111. Conde S.J., Luyvizotto R.A., Sfbio M.T. et al. Thyroid hormone profile in breast cancer patients in postmenopause. // Arq. Bras. Endocrinol. Metabol.

2012. Vol. 56. №4. P. 238-243.

112. Cooney C.S., Khouri N.F., Tsangaris T.N. The role of breast MRI in the management of patients with breast disease. // Advances in surgery. 2008. Vol. 42. P. 299-312.

113. Cox R.F., Morgan M.P. Microcalcifications in breast cancer: Lessons from physiological mineralization. Bone. 2013. Vol. 53. №2. P. 437-450.

114. Cristofanilli M., Yamamura Y., Kau S.W. et al. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. // Cancer. 2005. Vol. 103. №6. P. 1122-1128.

115. Cura del J.L., Elizagaray E., Zabala R. et al. The use of unenhanced Doppler sonography in the evaluation of solid breast lesions. // AJR Am. J. Roentgenol. 2005. Vol. 184. №6. P. 1788-1794.

116. Damle N.A., Bal C., Bandopadhyaya G.P. et al. The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and

prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan. // Jpn. J. Radiol. 2013. Vol. 31. №4. P. 262-269.

117. Daye D., Keller B., Conant E.F. et al. Mammographic parenchymal patterns as an imaging marker of endogenous hormonal exposure: a preliminary study in a high-risk population. // Acad. Radiol. 2013. Vol. 20. №5. P. 635-646.

118. De Silva N.K. Breast disorders in the female adolescent. // Adolesc. Med. State Art Rev. 2012. Vol. 23. №1. Р. 34-52.

119. Ditsch N., Liebhardt S., Von Koch F. et al. Thyroid function in breast cancer patients. // Anticancer Res. 2010. Vol. 30. №5. P. 1713-1717.

120. D'Orsi C.J., Newell M.S. On the frontline of screening for breast cancer. // Semin. Oncol. 2011. Vol. 38. №1. P. 119-127.

121. Drudi F.M., Cantisani V., Gnecchi M. et al. Contrast-enhanced ultrasound examination of the breast: a literature review. // Ultraschall Med. 2012. Vol. 33. №7. P. 1-7

122. Drukteinis J.S., Mooney B.P., Flowers C.I., Gatenby R.A. Beyond mammography: new frontiers in breast cancer screening. // Am. J. Med.

2013. Vol. 126. №6. P. 472-479.

123. Duffy S.W., Chen T.H.H., Yen A.M.F. et al. Methodologic Issues in the Evaluation of Service Screening. // Seminar in Breast Disease. 2007. №10. P. 68-71.

124. Ekmekcioglu O., Aliyev A., Yilmaz S. et al. Correlation of 18F- fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma. // Nucl. Med. Commun. 2013. Vol. 34. №11. P. 1055-1067.

125. Ellison-Loschmann L., McKenzie F., Highnam R. et al. Age and ethnic differences in volumetric breast density in New Zealand women: a crosssectional study. // PLoS One. 2013. Vol. 8. №7. P. e70217.

126. Erbas B., Amos A., Fletcher A. et al. Incidence of invasive breast cancer carcinoma in situ in a screening program by age: should older women

continue screening? // Cancer Epidemiol. Biomarkers Prev. 2004. Vol. 13. №10. Р. 1569-1573.

127. Eriksson L., Czene K., Rosenberg L. et al. Mammographic density and survival in interval breast cancers. // Breast Cancer Res. 2013. Vol. 15. №3. P. R48.

128. Esserman L., Shieh Y., Thompson I. Rethinking screening for breast cancer and prostate cancer. // JAMA. 2009. Vol. 302. №15. P. 1685-1692.

129. Farrokh A., Wojcinski S., Degenhardt F. et al. Evaluation of real-time tissue sono-elastography in the assessment of 214 breast lesions: limitations of this method resulting from different histologic subtypes, tumor size and tumor localization. // Ultrasound Med. Biol. 2013. Vol. 39. №12. P. 2264-2267.

130. Ferlay J., Shin H., Bray F. et al. GLOBOCAN-2008 v 3.0. Cancer incidence and mortality worldwide: IARC Cancer Base No. 10. International agency for research on cancer. URL: http://globocan.iarc.fr. (Дата обращения 03.09. 2013 г.).

131. Ferrara A. Nuclear imaging in breast cancer. // Radiol. Technol. 2010. Vol. 81. №3. P. 233-246.

132. Fleischer A.C., Niermann K.J., Donnelly E.F. et al. Sonographic depiction of microvessel perfusion: principles and potential. // J. Ultrasound Med. 2004. Vol. 23. №11. P. 1499-1506.

133. Fleury E.F., Fleury J.C., Piato S., Roveda D.Jr. New elastographic classification of breast lesions during and after compression. // Diagn. Interv. Radiol. 2009. Vol. 15. №2. P. 96-103.

134. Fournier A., Berrino F., Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. // Breast Cancer Res Treat. 2008. Vol. 107. №1. P. 103-111.

135. Fu L., Wang Y., Wang Y., Huang Y.-h. Value of ultrasound elastography in detecting small breast tumors. // Chin. Med. J. 2011. Vol. 124. №15. P. 2384-2386

136. Gadducci A., Guerrieri M.E., Genazzani A.R. Benign breast diseases, contraception and hormone replacement therapy. // Minerva Ginecol. 2012. Vol. 64. №1. P. 67-74.

137. Gallagher E.J., Leroith D. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire? // Curr. Opin. Endocrinol. Diabetes Obes. 2013. Vol. 20. №5. P. 485-494.

138. Garcia E.M., Storm E.S., Atkinson L., Kenny E., Mitchell L.S. Current breast imaging modalities, advances, and impact on breast care. // Obstet. Gynecol. Clin. North Am. 2013. Vol. 40. №3. P. 429-457.

139. Garcia-Manso A., Garcia-Orellana C.J., Gonzalez-Velasco H.M. et al. Study of the effect of breast tissue density on detection of masses in mammograms. // Comput. Math. Methods Med. 2013. URL: http://www.hindawi. com/journals/cmmm/2013/213794/. (Дата обращения

21.03.2014 г.).

140. Garcia-Robles M.J., Segura-Ortega J.E., Fafutis-Morris M. The biology of leptin and its implications in breast cancer: a general view. // J. Interferon Cytokine Res. 2013. Vol. 33. №12. P. 717-727.

141. Gheonea I.A., Donoiu L., Camen D. et al. Sonoelastography of breast lesions: a prospective study of 215 cases with histopathological correlation. // Rom. J. Morphol. Embryol. 2011. Vol. 52. №4. P. 1209-1214.

142. Gheonea I.A., Stoica Z., Bondari S. Differential diagnosis of breast lesions using ultrasound elastography. // Indian J. Radiol. Imaging. 2011. Vol. 21. №4. P. 301-305.

143. Ghosh K., Hartmann L.C., Reynolds C. et al. Association between mammographic density and age-related lobular involution of the breast. // JCO. 2010. Vol. 28. №13. P. 2207-2212.

144. Ginsburg O.M., Martin L.J., Boyd N.F. Mammographic density, lobular involution, and risk of breast cancer. // Br. J. Cancer. 2008. №99. P. 1369-1374.

145. Girardi V., Tonegutti M., Ciatto S., Bonetti F. Breast ultrasound in 22,131 asymptomatic women with negative mammography. // Breast. 2013. Vol. 22. №5. P. 806-809.

146. Giuseppetti G.M., Martegani A., Di Cioccio B., Baldassarre S. Elastosonography in the diagnosis of the nodular breast lesions: preliminary report. // Radiol. Med. 2005. Vol. 110. №1-2. P. 69-76.

147. Giustarini E., Pinchera A., Fierabracci P., et al. Thyroid autoimmunity in patients with malignant and benign breast diseases before surgery. // Eur. J. Endocrinol. 2006. Vol. 154. №5. P. 645-649.

148. Glass A.G., Lacey J.V. Jr., Carreon J.D., Hoover R.N. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. // J. Natl. Cancer Inst. 2007. Vol. 99. №15. P. 1152-1161.

149. Glide C., Duric N., Littrup P. Novel approach to evaluating breast density utilizing ultrasound tomography. // Med. Phys. 2007. №34. P. 744-753.

150. Goddi A., Bonardi M., Alessi S. Breast elastography: A literature review. // Journal of Ultrasound. 2012. №15. P. 192-198.

151. Gokalp G., Topal U., Kizilkaya E. Power Doppler sonography: anything to add to BI-RADS US in solid breast masses? // Eur. J. Radiol. 2009. Vol. 70. №1. P. 77-85.

152. Golatta M., Franz D., Harcos А. et al. Interobserver reliability of automated breast volume scanner (ABVS) interpretation and agreement of ABVS findings with hand held breast ultrasound (HHUS), mammography and pathology results. // Eur. J. Radiol. 2013. Vol. 82. №8. P. 332-336.

153. Gong X., Xu Q., Xu Z. et al. Real-time elastography for the differential of benign and malignant breast lesions: a meta-analysis // Breast Cancer Res. Treat. 2011. V. 130. №1. Р. 11-18.

154. Gorechlad J.W., McCabe E.B., Higgins J.H. et al. Screening for recurrences in patients treated with breast-conserving surgery: is there a role for MRI? // Annals of surgical oncology. 2008. Vol. 15. №6. P. 1703-1709.

155. Grimaldi-Bensouda L., Cameron D., Marty M. et. al. Risk of breast cancer by individual insulin use - an international multicenter study. // Diabetes Care. Vol. 37. №1. P. 134-143.

156. Guo Y.P., Martin L.J., Hanna W. et al. Growth factors and stromal matrix proteins associated with mammographic densities. // Cancer Epidemiol. Biomarkers Prev. 2001. №10. P. 243-248.

157. Guray M., Sahin A.A. Benign breast diseases: classification, diagnosis, and management. // Oncologist. 2006. Vol. 11. №5. Р. 435-449.

158. Gwak Y.J., Kim H.J., Kwak J.Y. et al. Ultrasonographic detection and characterization of asymptomatic ductal carcinoma in situ with histopathologic correlation. // Acta Radiol. 2011. Vol. 52. №4. P. 364-371.

159. Hajtmanova E., Murin P., Kinclova I. et al. Thyroid disorders in women with breast cancer. // Klin. Onkol. 2012. Vol. 25. №2. Р. 124-129.

160. Hamed S.T., Abdo M.H., Ahmed H.H. Breast discharge: ultrasound and Doppler evaluation. // J. Egypt Natl. Canc. Inst. 2008. Vol. 20. №3. P. 262-270.

161. Hardefeldt P.J., Eslick G.D., Edirimanne S. Benign thyroid disease is associated with breast cancer: a meta-analysis. // Breast Cancer Res. Treat. 2012. Vol. 133. №3. Р. 1169-1177.

162. Hartman S.J., Dunsiger S.I., Marcus B.H. A pilot study of a physical activity intervention targeted towards women at increased risk for breast cancer. // Psychooncology. 2013. Vol. 22. №2. P. 381-387.

163. Hartmann L.C., Sellers T.A, Frost M.H. et al. Benign breast disease and the risk of breast cancer. // N. Engl. J .Med. 2005. Vol. 353. №3. P. 229-237.

164. Harvey J.A., Gard C.C., Miglioretti D.L. et al. Reported mammographic density: film-screen versus digital acquisition. // Radiology. 2013. Vol. 266. №3. P. 752-758.

165. Hatzung G., Grunwald S., Zygmunt M. et al. Sonoelastography in the diagnosis of malignant and benign breast lesions: initial clinical experiences // Ultraschall Med. 2010. №31. №6. P. 596-603.

166. Hellevik A.I., Asvold B.O., Bjoro T. et al. Thyroid function and cancer risk: a prospective population study. // Cancer Epidemiol Biomarkers Prev. 2009. №18. P. 570-574.

167. Hendrick R.E. Breast MRI Fundamentals and Technical Aspects. N.Y.: Springer. 2008. 251 p.

168. Hofvind S., Ursin G., Tretli S. et al. Breast cancer mortality in participants of the Norwegian Breast Cancer Screening Program. // Cancer. 2013. Vol. 119. P. 3106-3112.

169. Hofwind S., Sakshaug S., Ursin G., Graff-Iversen S. Breast cancer incidence trends in Norway - explained by hormone therapy or mammographic screening? // Int. J. Cancer. 2012. Vol. 130. №12. Р. 2930-2938.

170. Hollenbeck S., Keely P., Seewaldt V. Mammographic density: intersection of science, the law, and clinical practice. // Am. Soc. Clin. Oncol. Educ. Book. 2013. P. 63-69

171. Hollowell J.G., Staehling N.W., Flanders W.D. et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). // J. Clin. Endocrinol Metab. 2002. Vol. 87. №2. P. 489-499.

172. Hong A.S., Rosen E.L., Soo M.S., Baker J.A. BI-RADS for sonography: positive and negative values of sonographic features. // Am. J. Roentgenol. 2005. V. 184. №4. Р. 1260-1265.

173. Hooley R.J., Greenberg K.L., Stackhouse R.M. et al. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act. // Radiology. 2012. Vol. 265. №1. P. 59-69.

174. Hoover D.J., Paragi P.R., Santoro E. et al. Prophylactic mastectomy in high risk patients: a practice-based review of the indications. Do we follow guidelines? // Breast Dis. 2010. Vol. 31. №1. Р. 19-27.

175. Horvath E., Silva C., Fasce G. et al. Parallel artery and vein: sign of benign nature of breast masses. // AJR Am. J. Roentgenol. 2012. Vol. 198. №1. P. W76-82.

176. Huang W., Fisher P.R., Dulaimy K. et al. Detection of breast malignancy: diagnostic MR protocol for improved specificity. // Radiology. 2004. №232. Р. 585-591.

177. Ikedo Y., Fukuoka D., Hara T. et al. Development of fully automatic scheme for detection of masses in whole breast ultrasound images. // Med. Phys. 2007. №34. P. 4378-4388.

178. International statistical classification of diseases and related health problems 10th revision (ICD-10). Version for 2010. URL: http://apps.who. int/classifications/icd10/browse/2010/en№/XIV. (Дата обращения 08.09. 2013 г.).

179. Irwig L., Houssami N., van Vliet C. New technologies in screening for breast cancer: a systematic review of their accuracy. // British Journal of Cancer. 2004. №90. Р. 2118-2122.

180. Itoh A., Ueno E., Tohno E., et al. Breast disease: clinical application of US elastography for diagnosis. // Radiology. 2006. Vol. 239. №2. Р. 341-350.

181. Jiskra J., Barkmanova J., Limanova Z. et al. Thyroid autoimmunity occurs more frequently in women with breast cancer compared to women with colorectal cancer and controls but it has no impact on relapse-free and overall survival. // Oncol. Rep. 2007. Vol. 18. №6. P. 1603-1611.

182. Joshi J.V., Pandey S.N., Galvankar P., Gogate J.A. Prevalence of premenstrual symptoms: preliminary analysis and brief review of management strategies. // J. Midlife Health. 2010. Vol. 1. №1. Р. 30-34.

183. Jung E.M., Jungius K.P., Rupp N. et al. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results. // Clin. Hemorheol. Microcirc. 2005. Vol. 33. №2. P. 109-120.

184. Jung K.W., Won Y.J., Kong H.J. et al. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. // Cancer Res. Treat. 2013. Vol. 45. №1. Р. 1-14.

185. Kabat G.C., Jones J.G., Olson N. et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer. // Cancer Causes Control. 2010. Vol. 21. №6. P. 821-828.

186. Kadour M.J., Adams R., English R. et al. Slip imaging: reducing ambiguity in breast lesion assessment // Ultrasound Med. Biol. 2010. Vol. 36. №12. P. 2027-2035.

187. Kaur N., Agarwal N., Parwar P. Clinicopathologic profile of benign breast conditions in Indian women. Prospective study based on aberrations of normal development and involution classification. // World J. Surgery. 2012. №36. P. 2252-2258.

188. Kerlikowske K., Zhu W., Hubbard R.A. et al. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. // JAMA Intern. Med. 2013. Vol. 173. №9. P. 807-816.

189. Khan N.F., Mant D., Carpenter L. et al. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study. // Br. J. Cancer. 2011. Vol. 105. Suppl. 1. P. S29-S37.

190. Kiely B.E., Hossack L.K., Shadbolt C.L. et al. Practicalities of developing a breast magnetic resonance imaging screening service for women at high risk for breast cancer. // ANZ J. Surg. 2011. Vol. 81. №10. P. 688-693.

191. Kim M.J., Kim J.Y., Yoon J.H. et al. How to find an isoechoic lesion with breast US. // Radiographics. 2011. Vol 31. №3. P. 663-676.

192. Kim M.Y., Cho N., Yi A. et al. Sonoelastography in distinguishing benign from malignant complex breast mass and making the decision to biopsy. // Korean J. Radiol. 2008. Vol. 14. №4. P. 559-567.

193. Kolaric D., Hercegy Z., Nola I.A. et al. Thermography - a feasible method for screening breast cancer? // Coll. Antropol. 2013. Vol. 37. №2. P. 583588.

194. Kontos M., Wilson R., Fentiman I. Digital infrared thermal imaging (DITI) of breast lesions: sensitivity and specificity of detection of primary breast cancers. // Clin. Radiol. 2011. Vol. 66. №6. P. 536-539.

195. Kopans D.B. Breast imaging. Lippincott Williams & Wilkins, 2007. 1114 p.

196. Kuijpens J.L., Nyklictek I., Louwman M.W. et al. Hypothyroidism might be related to breast cancer in post-menopausal women. // Thyroid. 2005. Vol. 15. №11. P. 1253-1259.

197. Kulie T., Slattengren A., Redmer J. et al. Obesity and women’s health: an evidence-based review. // J. Am. Board Fam. Med. 2011. №. 24. P. 75-85.

198. Kumar R. A clinicopathologic study of breast lumps in Bhairahwa, Nepal. // Asian Pac. J. Cancer Prev. 2010. Vol. 11. №4. P. 855-858.

199. Kumm T.R., Szabunio M.M. Elastography for the characterization of breast lesions: initial clinical experience. // Cancer Control. 2010. Vol. 17. №3. P. 156-161.

200. Kwak J.Y., Kim E.K., Kim M.J. et al. Power Doppler sonography: evaluation of solid breast lesions and correlation with lymph node metastasis. // Clin. Imaging. 2008. Vol. 32. №3. P. 167-171.

201. Kyriopoulos E., Kakagia D., Zapandioti P. et al. Pathologic findings in breast reduction specimens: detection of occult premalignant and cancerous lesions. // Onkologie. 2012. Vol. 35. №10. P. 583-586.

202. Lagiou P., Samoli E., Lagiou A. et al. A comparison of hormonal profiles between breast cancer and benign breast disease: a case-control study. // Ann. Oncol. 2013. Vol. 24. №10. P. 2527-2533.

203. Lai Y.C., Hsu C.Y., Chou Y.H. et al. Sonographic presentations of metaplastic breast cancers. // J. Chin. Med. Assoc. 2012. Vol. 75. №11. P. 589-594.

204. Lakhani S.R., Ellis I.O., Schnitt S.J. et al. WHO classification of tumours of the breast. Lyon: IARC, 2012. 240 p.

205. Largent J.A., Bernstein L., Horn-Ross P.L. et al. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. // Cancer Causes Control. 2010. Vol. 21. №10. P. 1615-1624.

206. Leconte I., Fellah L. US and dense breasts: where do we stand? // J. Radiol. 2008. Vol. 89. №9. P. 1169-1179.

207. Lee J.H., Kim S.H., Kang B.J. et al. Role and clinical usefulness of elastography in small breast masses. // Acad. Radiol. 2011. Vol. 18. №1. P. 74-80.

208. Li T., Sun L., Miller N. et al. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. // Cancer Epidemiol. Biomarkers Prev. 2005. №14. P. 343-349.

209. Li W., Ray R.M., Lampe J.W. et al. Dietary and other risk factors in women having fibrocystic breast conditions with and without concurrent breast cancer: a nested case-control study in Shanghai, China. // Int. J. Cancer. 2005. Vol. 115. №6. P. 981-993.

210. Lindfors K.K., Boone J.M., Nelson T.R. et al. Dedicated breast CT: initial clinical experience. // Radiology. 2008. Vol. 246. №3. P. 725-733.

211. Liu Y., Cheng H.D., Huang J.H. et al. Computer aided diagnosis system for breast cancer based on color Doppler flow imaging. // J. Med. Syst. 2012. Vol.36. №6. P. 3975-3982.

212. Liu Y., Tamimi R.M., Berkey C.S. et al. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. // Pediatrics. 2012. Vol. 128. №5. P. 1192-1198.

213. Lopez-Fontana C.M., Sasso C.V., Maselli M.E. et al. Experimental hypothyroidism increases apoptosis in dimethylbenzanthracene-induced mammary tumors. // Oncol. Rep. 2013. Vol. 30. №4. Р. 1651-1660.

214. Loveless M.E., Li .X, Huamani J., Lyshchik A. A method for assessing the microvasculature in a murine tumor model using contrast-enhanced ultrasonography. // J. Ultrasound Med. 2008. Vol. 27. №12. P. 1699-1709.

215. Malich A., Bohm T., Facius M. et al. Electrical impedance scanning as a new imaging modality in breast cancer detection - a short review of clinical value on breast application, limitations and perspectives. // Nucl. Instrum. Meth. A. 2003. №497. P. 75-81.

216. Mansour S.M., Omar O.S. Elastography ultrasound and questionable breast lesions: does it count? // Eur. J. Radiol. 2012. Vol. 81. №11. P. 3234-3244.

217. Martinez-Iglesias O., Garcia-Silva S., Regadera J., Aranda A. Hypothyroidism enhances tumor invasiveness and metastasis development. // PLoS One. 2009. Vol. 4. №7. e6428. 11 p.

218. Massardo T., Alonso O., Llamas-Ollier A. et al. Planar Tc99m-sestamibi

scintimammography should be considered cautiously in the axillary evaluation of breast cancer protocols: results of an international multicenter trial. // BMC Nucl. Med. 2005. Vol. 5. №4.

[URL: http://www.biomedcentral.com/1471-2385/5/4. Дата последнего обращения 28.03.2014].

219. Mesaki K., Hisa N., Kubota K. et al. Differentiation of benign and malignant breast tumors using Doppler spectral parameters including acceleration time index. // Oncol. Rep. 2003. Vol. 10. №2. P. 945-950.

220. Milanese T.R., Hartmann L.C., Sellers T.A. et al. Age-related lobular involution and reduced risk of breast cancer. // J. Natl. Cancer Inst. 2006. №98. P. 1600-1607.

221. Milanovic R., Roje Z., Korusic A. et al. Clinical and patohistological factors affecting the 5 year survival rate in a population of Croatian women with invasive ductal breast carcinoma. // Coll. Antropol. 2013. Vol. 37. №2. P. 459-464.

222. Mizota Y., Yamamoto S. Prevalence of breast cancer risk factors in Japan. // Jpn. J. Clin. Oncol. 2012. Vol. 42. №11. Р. 1008-1012.

223. Moeller L.C., Fuhrer D. Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. // Endocr. Relat. Cancer. 2013. Vol. 20. №2. P. 19-29.

224. Morris E.A., Liberman L. Breast MRI: diagnosis and intervention. N.Y.: Springer. 2005. P. 3-23.

225. Muller I., Pinchera A., Fiore E. et al. High prevalence of breast cancer in patients with benign thyroid diseases. // J. Endocrinol. Invest. 2011. Vol. 34. №5. P. 349-352.

226. Murphy C.D., Lee J.M., Drohan B. et al. The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. // Cancer. 2008. Vol. 113. №11. Р. 3116-3120.

227. Nadrljanski M.M., Markovic B.B., Milosevic Z.C. Breast ductal carcinoma in situ: morphologic and kinetic MRI findings. // Iran. J. Radiol. 2013. Vol. 10. №2. P. 99-102.

228. Ng E.Y.K. A review of thermography as promising noninvasive detection modality for breast tumour. // Int. J. Therm. Sci. 2009. №48. P. 849-859.

229. Nofiele J.T., Cheng H.L. Ultrashort echo time for improved positive- contrast manganese-enhanced MRI of cancer. 2013. Vol. 8. №3. P. e58617.

230. O’Connell A., Conover D.L., Zhang Y. et al. Cone-Beam CT for Breast Imaging: Radiation Dose, Breast Coverage and Image Quality. // AJR. 2010. Vol. 195. P. 496-509.

231. Okoth C., Galukande M., Jombwe J., Wamala D. Benign proliferative breast diseases among female patients at a sub-Saharan Africa tertiary hospital: a cross sectional study. // BMC Surg. 2013. Vol. 13. №9. URL: http://www.biomedcentral.com/1471-2482/13/9. (Дата обращения 17.03. 2014 г.).

232. Olawaiye A., Withiam-Leitch M., Danakas G., Kahn K. Mastalgia: a review of management. //. J. Reprod. Med. 2005. Vol. 50. №12. P. 933-939.

233. Orgeas C.C., Hall P., Rosenberg L.U., Czene K. The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer. // Breast Cancer Res. 2008. Vol. 10. №6. R. 107.

234. Ozdemir A., Ozdemir H., Maral I. et al. Differential diagnosis of solid breast lesions: contribution of Doppler studies to mammography and gray scale imaging // J. Ultrasound Med. 2001. V. 20. №10. Р. 1091-1101.

235. Pandey S., Chandravati. Breast screening in north India: a cost-effective cancer prevention strategy. // Asian Pac. J. Cancer Prev. 2013. Vol. 14. №2. P. 853-857.

236. Parajuly S.S., Lan;Y., Yan L. et al. Breast elastography: a hospital-based preliminary study in China. // Asian Pac. J. Cancer Prev. 2010. Vol. 11. №3. P. 809-814.

237. Park S.K., Kim Y., Kang D. et al. Risk Factors and Control Strategies for the Rapidly Rising Rate of Breast Cancer in Korea. // J. Breast Cancer. 2011. Vol. 14. №2. P. 79-87.

238. Parkin D.M. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. // Br. J. Cancer. 2011. №105. Suppl. 2. S. 2-5.

239. Parkin D.M., Boyd L., Walker L.C. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Summary and conclusions. // Br. J. Cancer. 2011. №105. S. 77-81

240. Parris T., Wakefield D., Frimmer H. Real world performance of screening breast ultrasound following enactment of Connecticut Bill 458. // Breast J. 2013. Vol. 19. №1. P. 64-70.

241. Pavic D., Koomen M., Kuzmiak C., Pisano E.D. Ultrasound in the management of breast disease. // Curr. Womens Health Rep. 2003. Vol. 3. №2. P. 156-164.

242. Pearce E.N., Farwell A.P., Braverman L.E. Thyroiditis. // NEJM. 2003. Vol. 348. P. 2646-2655.

243. Pfeiffer R.M., Park Y., Kreimer A.R. et al. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. // PLoS Med. Vol. 10. №7. URL: http://dx.plos.org/10.1371/journal.pmed.1001492. (Дата обращения 17.03.2014 г.).

244. Pinder S.E. Ductal carcinoma in situ (DCIS): pathological features, differential diagnosis, prognostic factors and specimen evaluation. // Mod. Pathol. 2010. №23. Suppl. 2. P. 8-13.

245. Pinero A., Reus M., Illana J. et al. Palpable breast lesions: utility of Doppler sonography for diagnosis of malignancy. // Breast. 2003. Vol. 12. №4. P. 258-263.

246. Pisano E.D., Gatsonis C., Hendrick E. et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. // NEJM. 2005. №353. P. 1773-1783.

247. Popiel M., Mroz-Klimas D., Kasprzak R., Furmanek M. Mammary carcinoma - current diagnostic methods and symptomatology in imaging studies. // Pol. J. Radiol. 2012. Vol. 77. №4. P. 437-450.

248. Popiela T.J., Kibil W., Herman-Sucharska I., Urbanik A. The use of magnetic resonance mammography in women at increased risk for developing breast cancer. // Wideochir. Inne. Tech. Malo Inwazyjne. 2013. Vol. 8. №1. P. 55-62.

249. Prasad S.N., Houserkova D. A comparison of mammography and ultrasonography in the evaluation of breast masses. // Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech Repub. 2007. Vol. 151. №2. P. 315-322.

250. Prionas N.D., Lindfors K.K., Ray S. et al. Contrast-enhanced Dedicated Breast CT: Initial Clinical Experience. // Radiology. 2010. Vol. 256. №3. P. 714-723.

251. Rakha E.A., O'Toole S.A., Ellis I.O., Tan P.H. Breast pathology today: morphology and molecules. // J. Clin. Pathol. 2013. Vol. 66. №6. Р. 457.

252. Raza S., Odulate A., Ong E.M. et al. Using real-time tissue elastography for breast lesion evaluation: our initial experience // J. Ultrasound Med. 2010. V. 29. №4. Р. 551-563.

253. Razzaghi H., Troester M.A., Gierach G.L. et al. Mammographic density and breast cancer risk in White and African American Women. // Breast Cancer Res Treat. 2012. Vol. 135. №2. P. 571-580.

254. Razzaghi H., Troester M.A., Gierach G.L. Association between mammographic density and basal-like and luminal A breast cancer subtypes. // Breast Cancer Res. 2013. Vol. 15. №5. URL.: http://breast-cancer-research. com/content/15/5/R76. (Дата последнего обращения 30.03.2014 г.).

255. Regini E., Bagnera S., Tota D. et al. Role of sonoelastography in characterising breast nodules. Preliminary experience with 120 lesions. // Radiol. Med. 2010. Vol. 115. №4. P. 551-562.

256. Ren B., Smith A.P., Marshall J. Investigation of practical scoring methods for breast density. // Lecture Notes in Computer Science. 2010. №6136. P. 651-658.

257. Reynolds A. Breast density and digital breast tomosynthesis. // Radiol. Technology. 2013. Vol. 85. №1. P. 63-82.

258. Rjosk-Dendorfer D., Gurtler V.M., Sommer W. et al. Value of high resolution compression elastography and color doppler sonography in characterisation of breast lesions: Comparison of different high-frequency transducers. // Clin. Hemorheol. Microcirc. 2014. URL: http://www.ncbi. nlm.nih.gov/pubmed/24584321. (Дата обращения 16.04.2014).

259. Roberts G.P., Ladenson P.W. Hypothyroidism. // Lancet. 2004. Vol. 363. P. 793-803.

260. Rosato V., Bosetti C., Talamini R. et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women. // Ann. Oncol. 2011. Vol. 22. №12. P. 2687-2692.

261. Sadigh G., Carlos R.C., Neal C.H., Dwamena B.A. Ultrasonographic differentiation of malignant from benign breast lesions: a meta-analytic

comparison of elasticity and BIRADS scoring. // Breast Cancer Res. Treat. 2012. №133. P. 23-35.

262. Sahiner B., Chan H.P., Roubidoux M.A. et al. Malignant and benign breast masses on 3D US volumetric images: Effect of computer-aided diagnosis on radiologist accuracy. // Radiology. 2007. Vol. 242. №3. P. 716-724.

263. Salem D.S., Kamal R.M., Mansour S.M. Breast imaging in the young: the role of magnetic resonance imaging in breast cancer screening, diagnosis and follow-up. // J. Thorac Dis. 2013. №5. Suppl. 1. P. S9-S18.

264. Sandberg M.E., Li J., Hall P. et al. Change of mammographic density predicts the risk of contralateral breast cancer: a case-control study. // Breast Cancer Res. 2013. Vol. 15. №4. P. R57.

265. Sandhu M.K., Brezden-Masley C., Lipscombe L.L. et al. Autoimmune hypothyroidism and breast cancer in the elderly. // Breast Cancer Res. Treat. 2009. №115. P. 635-641.

266. Sangma M.B.M., Panda K., Dasiah S. A clinico-pathological study on benign breast diseases. // J. Clin. Diagn. Res. 2013. Vol. 7. №3. Р. 503-506.

267. Santen R.J. Assessing individual risk for breast cancer: role of oestrogens and androgens. // Breast Cancer Res. 2008. №10. Suppl. 4. S. 10.

268. Santen R.J., Mansel R. Benign breast disorders. // N. Engl J Med. 2005. Vol. 353. №3. P. 275-285.

269. Sarvazyan A., Egorov V. Mechanical Imaging - a technology for 3-D visualization and characterization of soft tissue abnormalities. A review. // Curr. Med. Imaging Rev. Vol. 8. №1. P. 64-73.

270. Scaperrotta G., Ferranti C., Costa C. et al. Role of sonoelastography in nonpalpable breast lesions // Eur. Radiol. 2008. V. 18. №11. Р. 2381-2389.

271. Schilling K., Narayanan D., Kalinyak J.E. Effect of breast density, menopausal status, and hormone use in high resolution positron emission mammography. // Radiol. Soc. North. Am. 2008. VB. 31-04.

272. Schousboe J.T., Kerlikowske K., Loh A., Cummings S.R. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. // Ann. Intern. Med. 2011. Vol. 155. №1. P. 10-20.

273. Schroeder R.J., Bostanjoglo M., Rademaker J. et al. Role of power Doppler techniques and ultrasound contrast enhancement in the differential diagnosis of focal breast lesions. // European radiology. 2003. Vol. 13. №1. P. 68-79.

274. Sechopoulos I., Feng S.S., D'Orsi C.J. Dosimetric characterization of a dedicated breast computed tomography clinical prototype. // Med. Phys. 2010. Vol. 37. №8. P. 4110-4120.

275. Sehgal C.M., Weinstein S.P., Arger P.H., Conant E.F. A review of breast ultrasound. // J. Mammary Gland. Biol. Neoplasia. 2006. Vol. 11. №2. P. 113-123.

276. Selvan S., Kavitha M., Devi S.S., Suresh S. Fuzzy-based classification of breast lesions using ultrasound echography and elastography. // Ultrasound Q. 2012. Vol. 28. №3. P. 159-167.

277. Shao Z., Weang H., Li X. et al. Morphological distribution and internal enhancement architecture of contrast-enhanced magnetic resonance imaging in the diagnosis of non-mass-like breast lesions: a meta-analysis. // Breast J. 2013. Vol. 19. №3. P. 259-268.

278. Shen Z.Y., Hu B., Wu M.F. Correlation between Blood Flow Signal of Color Flow Imaging and Nottingham Prognostic Index in Patients with Breast Carcinoma. // Breast Care. 2012. Vol. 7. №2. P. 126-130.

279. Simon M.S., Taneg M.T., Bernstein L. Do thyroid disorders increase the risk of breast cancer? // Cancer Epidemiol. Biomarkers Prev. 2002. Vol. 11. №12. P. 1574-1578.

280. Sinclair N., Littenberg B., Geller B, Muss H. Accuracy of screening mammography in older women. // AJR Am. J. Roentgenol. 2011. Vol. 197. №5. P. 1268-1273.

281. Smallridge R.C. Thyroid autoimmunity and breast cancer - cause or effect? // Nat. Clin. Pract. Endocrinol. Metab.2006. Vol 2. №12. P. 660-661.

282. Smetherman D.H. Screening, imaging, and image-guided biopsy techniques for breast cancer. // Surg. Clin. North. Am. 2013. Vol. 93. №2. P. 309-327.

283. Smith R.A., Duffy S.W., Gabe R. et al. The randomised trials of breast cancer screening what have we learned. // Radiol. Clin. N. Am. 2004. №42. P. 793-806.

284. Sohn Y.M., Kim M.J., Kim E.K. et al. Sonographic elastography combined with conventional sonography: how much is it helpful for diagnostic performance? // J. Ultrasound Med. 2009. V. 28. № 4. Р. 413-420.

285. Soo M.S., Baker J.A., Rosen E.L. Sonographic detection and sonographically guided biopsy of breast microcalcifications. // AJR. American journal of roentgenology. 2003. Vol. 180. №4. P. 941-948.

286. Sree S.V., Ng E.Y., Acharya R.U., Faust O. Breast imaging: a survey. // World J. Clin. Oncol. 2011. Vol. 2. №4. P. 171-178.

287. Stachs A., Hartmann S., Stubert J. et al. Differentiating between malignant and benign breast masses: factors limiting sonoelastographic strain ratio. // Ultraschall Med. 2013. Vol. 34. №2. P. 131-136.

288. Stewart V.R., Sidhu P.S. New directions in ultrasound: microbubble contrast. // Br. J. Radiology. 2006. №79. P. 188-194.

289. Stoblen F., Landt S., Ishaq R. et al. High-frequency breast ultrasound for the detection of microcalcifications and associated masses in BI-RADS 4a patients. // Anticancer Res. 2011. Vol. 31. №8. P. 2575-2581.

290. Suh Y.J., Kim M.J., Kim E.K. et al. Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14- gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy. // Br. J. Radiol. 2012. Vol. 85. №1016. P. 346-356.

291. Surks M.I., Ortiz E., Daniels G.H. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. // JAMA. 2004. Vol. 291. №2. P. 228-238.

292. Surti S. Radionuclide methods and instrumentation for breast cancer detection and diagnosis. // Semin. Nucl. Med. 2013. Vol. 43. №4. P. 271-280.

293. Svensson W.E., Pandian A.J., Hashimoto H. The use of breast ultrasound color Doppler vascular pattern morphology improves diagnostic sensitivity with minimal change in specificity. // Ultraschall Med. 2010. Vol. 31. №5. P. 466-474.

294. Tabar L., Tot T., Dean P.B. Breast cancer. Early detection with mammography. Casting type calcification: sign of a subtype with descriptive features. Stuttgart. New York: Thieme, 2007. 313 p.

295. Tabar L., Vitak B., Chen T.H.-H. et al. Swedish Two-County Trial: Impact of Mammographic Screening on Breast Cancer Mortality during 3 Decades. // Acta. Radiol. 2011. №52. Р. 1061-1063.

296. Tardivon A., El Khoury C., Thibault F. et al. Elastosonographie du sein: etude prospective de 122 lesions. // J. Radiol. 2007. Vol. 88. №5. P. 657-662.

297. Taskin F., Koseoglu K., Ozbas S., Erkus M., Karaman C. Sonographic features of histopathologically benign solid breast lesions that have been classified as BI-RADS 4 on sonography. // J. Clin. Ultrasound. 2012. Vol. 40. №5. P. 261-265.

298. Taskin F., Koseoglu K., Unsal A. et al. Sclerosing adenosis of the breast: radiologic appearance and efficiency of core needle biopsy. // Diagn. Interv. Radiol. 2011. Vol. 17. №4. P. 311-316.

299. Tejwani P.L., Srivastava A. Nerkar H. et al. Centchroman regresses mastalgia: a randomized comparison with danazol. // Indian J. Surg. 2011. Vol. 73. №3. P. 199-205.

300. Tesic V., Kolaric B., Znaor A. et al. Mammographic density and estimation of breast cancer risk in intermediate risk population. // Breast J. 2013. Vol. 19. №1. P. 71-78.

301. Thibault F., Dromain C., Breucq C. et al. Digital breast tomosynthesis versus mammography and breast ultrasound: a multireader performance study. // Eur. Radiol. 2013. Vol. 23. №9. P. 2441-2449.

302. Thicke L.A., Hazelton J.K., Bauer B.A. et al. Acupuncture for treatment of noncyclic breast pain: a pilot study. // Am. J. Chin. Med. 2011. Vol. 39. №6. P. 1117-1129.

303. Thomas A., Fischer T., Frey H. et al. Real-time elastography - an advanced method of ultrasound: First results in 108 patients with breast lesions. // Ultrasound Obstet. Gynecol. 2006. Vol. 28. №3. P. 335-340.

304. Thurfjell E. Breast density and the risk of breast cancer. // N. Engl. J. Med. 2002. №347. P. 866.

305. Tice J.A., O'Meara E.S., Weaver D.L. et al. Benign breast disease, mammographic breast density, and the risk of breast cancer. // J. Natl. Cancer Inst. 2013. Vol. 105. №14. P. 1043-1049.

306. Tiu C.M., Chou Y.H., Chiou S.Y. et al. Development of a carcinoma in situ in a fibroadenoma: color Doppler sonographic demonstration. // J. Ultrasound Med. 2006. Vol. 25. №10. P. 1335-1338.

307. Tohno E., Ueno E. Current improvements in breast ultrasound, with a special focus on elastography. // Breast Cancer. 2008. №15. P. 200-204.

308. Tohno E., Ueno E. Ultrasound (US) diagnosis of nonpalpable breast cancer. // Breast Cancer. 2005. Vol. 12. №4. P. 267-271.

309. Tosovic A., Becker C., Bondeson A.G. et al. Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk. // Int. J. Cancer. 2012. Vol. 131. №9. P. 2126-2133.

310. Tosovic A., Bondeson A.G., Bondeson L. et al. Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women. // Breast Cancer Res. 2010. Vol. 12. №3. P. R33.

311. Tozaki M., Fukuma E. Does power Doppler ultrasonography improve the BI-RADS category assessment and diagnostic accuracy of solid breast lesions? // Acta Radiol. 2011. Vol. 52. №7. P. 706-710.

312. Trocchi P., Ursin G., Kuss O. et al. Mammographic density and interobserver variability of pathologic evaluation of core biopsies among women with mammographic abnormalities. // BMC Cancer. 2012. Vol. 12. №554. URL: http:// www.biomedcentral.com/1471-2407/12/554. (Дата обращения

19.03.2014 г.).

313. Tsai C.J., Chen R.C., Peng H. et al. Improved microcalcification visualization using dual-energy digital mammography. Acta Radiol. // 2013. Vol. 54. №6. P. 614-621.

314. Tsuchiya S.I., Yamaguchi R., Tsuchiya K., Ohashi R. Characteristics of the Japanese histological classification for breast cancer: correlations with imaging and cytology. // Breast Cancer. 2013. URL: http://link.springer.com/ article/10.1007%2Fs12282-013-0488-9. (Дата обращения 17.03. 2014 г.).

315. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2009 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2013.

316. Uematsu T. Non-mass-like lesions on breast ultrasonography: a systematic review. // Breast Cancer. 2012. Vol. 19. №4. P. 295-301.

317. Vachon C.M., Brandt K.R., Ghosh K. et al. Mammographic breast density as a general marker of breast cancer risk. // Cancer Epidemiol. Biomarkers Prev. 2007. №16. P. 43-49.

318. Vaidyanathan K., Lakhotia S., Ravishankar H.M. et al. BRCA1 and BRCA2 germline mutation analysis among Indian women from south India: identification of four novel mutations and high-frequency occurrence of 185delAG mutation. // J. Biosci. Vol. 34. №3. 2009. p. 415-422.

319. Vallone P., D'Angelo R., Filice S. et al. Color-doppler using contrast medium in evaluating the response to neoadjuvant treatment in patients with locally advanced breast carcinoma. // Anticancer research. 2005. Vol. 25. №1. P. 595-599.

320. Vierkant R.A., Hartmann L.C., Pankratz V.S. et al. Lobular involution: Localized phenomenon or field effect? // Breast Cancer Res. Treat. 2009. №117. P. 193-196.

321. Vilaprinyo E., Puig T., Rue M. Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain. // PLoS One. 2012. Vol. 7. №1. E. e30157.

322. Vreugdenburg T.D., Willis C.D., Mundy L., Hiller J.E. A systematic review of elastography, electrical impedance scanning, and digital infrared thermography for breast cancer screening and diagnosis. // Breast Cancer Res. Treat. 2013. Vol. 137. №3. P. 665-676.

323. Wang J., Joseph P.C., Tan-Chiu E. et al. Lower category benign breast disease and the risk of invasive breast cancer. // J. Natl. Cancer Inst. 2004. Vol. 96. №8. Р. 616-620.

324. Wang K., Wang T., Fu F. et al. Electrical impedance scanning in breast tumor imaging: correlation with the growth pattern of lesion. // Chin. Med. J. 2009. Vol. 122. №13. P.1501-1506.

325. Wang S., Delproposto Z., Wang H. et al. Differentiation of breast cancer from fibroadenoma with dual-echo dynamic contrast-enhanced MRI. // PLoS One. 2013. Vol. 8. №7. P. e67731.

326. Wang S.Y., Virnig B.A., Tuttle T.M. et al. Variability of Preoperative Breast MRI Utilization among Older Women with Newly Diagnosed Early- stage Breast Cancer. // Breast J. 2013. Vol. 19. №6. P. 627-636.

327. Wang Z., Yang T., Wu Z. Correlation between elastography score and strain rate ratio in breast small tumor. // Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010. Vol. 35. №9. P. 928-933.

328. Warren R., Lakhani S.R. Can the stroma provide the clue to the cellular basis for mammographic density? // Breast Cancer Res. 2003. №5. P. 225-227.

329. Wartofsky L., Dickey R.A. The evidence for a narrower thyrotropin reference range is compelling. // J. Clin. Endocrinol. Metab. 2005. Vol. 90. №9. P. 5483-5489.

330. Weir R., Day P., Ali W. Risk factors for breast cancer in women. A systematic review of the literature. // NZHTA REPORT. 2007. №2. P. 13-28.

331. Weismann C., Mayr C., Egger H., Auer A. Breast sonography - 2D, 3D, 4D ultrasound or elastography? // Breast Care. 2011. Vol. 6. №2. P. 98-103.

332. Weisstock C.R., Rajapakshe R., Bitgood C. et al. Assessing the breast cancer risk distribution for women undergoing screening in British Columbia. // Cancer Prev. Res. (Phila). 2013. Vol. 6. №10. P. 1084-1092.

333. Wojcinski S., Boehme E., Farrokh A. et al. Ultrasound real-time elastography can predict malignancy in BI-RADS(R)-US 3 lesions. // BMC Cancer. 2013. Vol. 13. №159. URL: http:www.biomedcentral.com/1471- 2407/13/159. Дата обращения 01.02.2014 г.).

334. Wu C., Ray R.M., Lin M.G. et al. A case-control study of risk factors for fibrocystic breast conditions: Shanghai Nutrition and Breast Disease Study, China, 1995-2000. // Am. J. Epidemiol. 2004. Vol. 160. №10. P. 945-960.

335. Xia J.Q., Lo J.Y., Yang K. et al. Dedicated breast computed tomography: volume image denoising via a partial-diffusion equation based technique. // Med. Phys. 2008. Vol. 35. №5. P. 1950-1958.

336. Xu H.B., Li L., Xu Q. Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-analysis and meta-regression. // Nucl. Med. Commun. 2011. Vol. 32. №11. P. 980-988.

337. Yaffe M.J. Measurement of mammographic density. // Breast Cancer Research. 2008. Vol. 10. №209. URL: http://breast-cancer-research.com/ content/10/3/209. (Дата последнего обращения 15.09. 2013 г.).

338. Yang W., Dempsey P.J. Diagnostic breast ultrasound: current status and future directions. // Radiol. Clin. North Am. 2007. Vol. 45. №5. P. 845-861.

339. Yang W.T., Tse G.M. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. // AJR Am. J. Roentgenol. 2004. Vol. 182. №1. P. 101-110.

340. Yankaskas B.C., May R.C., Matuszewski J. et al. Effect of observing change from comparison mammograms on performance of screening mammography in a large community-based population. // Radiology. 2011. Vol. 261. №3. P. 762-770.

341. Yoon J.H., Kim M.H., Kim E.K. et al. Interobserver variability of ultrasound elastography: how it affects the diagnosis of breast lesions. // Am. J. Roentgenol. 2011. №196. P. 730-736.

342. Yoon J.H., Kim M.J., Kim E.K. et al. Discordant elastography images of breast lesions: how various factors lead to discordant findings. // Ultraschall Med. 2013. Vol. 34. №3. P. 266-271.

343. Yoon J.H., Ko K.H., Jung H.K., Lee J.T. Qualitative pattern classification of shear wave elastography for breast masses: how it correlates to quantitative measurements. // Eur. J. Radiol. 2013. Vol. 82. №12. P. 2199-2204.

344. Zdemir A., Kilic K., Ozdemir H. et al. Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography. // Journal of ultrasound in medicine. 2004. Vol. 23. №2. P. 183-195.

345. Zhu Q.L., Jiang Y.X., Liu J.B. et al. Real-time ultrasound elastography: its potential role in assessment of breast lesions. // Ultrasound Med. Biol. 2008. № 34. Р. 1232-1238.